Enhancing Renal Masses With Zero Net Growth During Active Surveillance
Authors:
- 1 March 2007
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 177 (3) , 849-854
Abstract
The natural history of small renal masses is generally to slowly increase in size. However, a subset of lesions does not show radiographic growth. We compared clinical, radiographic and pathological characteristics of enhancing renal masses under active surveillance with zero net radiographic growth vs those with positive growth. We identified 106 enhancing renal masses that were observed for 12 months or greater. Lesions were grouped according to growth characteristics. Group 1 consisted of lesions demonstrating zero or negative growth. Group 2 tumors showed positive growth during surveillance. Clinical, radiographic and pathological parameters were then compared. A MEDLINE search was performed regarding zero growth lesions during observation for suspected renal cell carcinoma in the world literature. Group 1 consisted of 35 lesions (33%) with a median growth rate of 0.0 cm yearly. Group 2 included 70 lesions (67%) showing growth at 0.31 cm yearly (p<0.0001). No differences were detected with regard to patient age (p=0.96), lesion size (p=0.41), solid/cystic appearance (p=1.00) or the incidental detection rate (p=0.38). While 17% of group 1 lesions (6 of 35) underwent intervention, 51% (36 of 71) in group 2 were ultimately treated (p=0.001). Pathological assessment showed a similar incidence of malignancy in groups 1 and 2 (83% and 89%, respectively, p=0.56). A literature review revealed that 78 of 295 observed lesions (26%) failed to demonstrate radiographic growth. We were unable to identify definable clinical characteristics to predict the future growth of enhancing renal masses under active surveillance. Our analysis demonstrated that 26% to 33% of these tumors do not demonstrate growth at 29 months median followup. These lesions have similar rates of malignancy compared to growing lesions and rates of progression to metastatic disease are similarly low. A brief period of active surveillance may be feasible with treatment limited to lesions that increase in size.Keywords
This publication has 18 references indexed in Scilit:
- The Natural History of Observed Enhancing Renal Masses: Meta-Analysis and Review of the World LiteratureJournal of Urology, 2006
- Laparoscopic Partial Nephrectomy: 3-Year FollowupJournal of Urology, 2006
- INDEPENDENT VALIDATION OF THE 2002 AMERICAN JOINT COMMITTEE ON CANCER PRIMARY TUMOR CLASSIFICATION FOR RENAL CELL CARCINOMA USING A LARGE, SINGLE INSTITUTION COHORTJournal of Urology, 2005
- Management of renal masses in patients medically unsuitable for nephrectomy—natural history, complications, and outcomeUrology, 2004
- The natural history of incidentally detected small renal massesCancer, 2004
- Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized TrialJournal of Clinical Oncology, 2003
- THE NATURAL HISTORY OF SMALL RENAL MASSESJournal of Urology, 2000
- NEPHRON SPARING SURGERY FOR LOCALIZED RENAL CELL CARCINOMA: IMPACT OF TUMOR SIZE ON PATIENT SURVIVAL, TUMOR RECURRENCE AND TNM STAGINGJournal of Urology, 1999
- Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 1998
- Increased incidence of serendipitously discovered renal cell carcinomaUrology, 1998